These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Dosage of the new oral anticoagulants is essential for frequency of adverse events]. Kræmmer Nielsen H. Ugeskr Laeger; 2013 Feb 04; 175(6):331. PubMed ID: 23402233 [No Abstract] [Full Text] [Related]
6. Place of dabigatran in contemporary pharmacotherapy. Gums JG. Pharmacotherapy; 2011 Apr 04; 31(4):335-7. PubMed ID: 21449622 [No Abstract] [Full Text] [Related]
8. Dabigatran in recurrent deep vein thrombosis: when one-size does not fit all. Twig G, Furer A, Yaniv G, Michael L, Karplus R, Amital H. Isr Med Assoc J; 2012 Jul 04; 14(7):454-5. PubMed ID: 22953626 [No Abstract] [Full Text] [Related]
13. New oral anticoagulants and risks in ENT. Hollis S. Clin Otolaryngol; 2013 Aug 04; 38(4):355-7. PubMed ID: 23957550 [No Abstract] [Full Text] [Related]
16. The Food and Drug Administration decision not to approve the 110 mg dose of dabigatran: give us a way out. Kowey PR, Naccarelli GV. Am J Med; 2012 Aug 04; 125(8):732. PubMed ID: 22608987 [No Abstract] [Full Text] [Related]
17. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Eikelboom JW, Wallentin L, Connolly SJ, Ezekowitz M, Healey JS, Oldgren J, Yang S, Alings M, Kaatz S, Hohnloser SH, Diener HC, Franzosi MG, Huber K, Reilly P, Varrone J, Yusuf S. Circulation; 2011 May 31; 123(21):2363-72. PubMed ID: 21576658 [Abstract] [Full Text] [Related]
18. Thrombosis on a mechanical mitral valve anticoagulated with dabigatran. Coulter S, Campos K. J Thromb Thrombolysis; 2014 May 31; 37(2):84-6. PubMed ID: 23813022 [No Abstract] [Full Text] [Related]